Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Mbio|April 30, 2020
Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic AnalysesNancy A Chow, José F Muñoz, Lalitha Gade, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2018
<i>In Vitro</i> and <i>In Vivo</i> Efficacy of a Novel and Long-Acting Fungicidal Azole, PC1244, on Aspergillus fumigatus InfectionThomas Colley, Gurpreet Sehra, Anuradha Chowdhary, et al.
Journal of Clinical Microbiology|September 8, 2021
Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 PatientsMehmet Ergün, Roger J M Brüggemann, Alexandre Alanio, et al.
Medical Mycology|March 25, 2026
A decade of ocular fungal infections due to Penicillium-like fungi in France (2012 to 2021)Lorra Monpierre, Eric Dannaoui, Olivier Lortholary, et al.
Genetics|July 7, 2017
Tracing Genetic Exchange and Biogeography of <i>Cryptococcus neoformans</i> var. <i>grubii</i> at the Global Population LevelJohanna Rhodes, Christopher A Desjardins, Sean M Sykes, et al.
Eclinicalmedicine|March 14, 2025
The diagnosis of mucormycosis by PCR in patients at risk: a systematic review and meta-analysisLottie Brown, Lena Tschiderer, Alexandre Alanio, et al.
Trials|January 16, 2019
Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority TrialDavid S Lawrence, Nabila Youssouf, Síle F Molloy, et al.
Trials|November 25, 2018
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority TrialDavid S Lawrence, Nabila Youssouf, Síle F Molloy, et al.
Nature Communications|September 27, 2024
Evolutionary origin and population diversity of a cryptic hybrid pathogenJacob L Steenwyk, Sonja Knowles, Rafael W Bastos, et al.
RMD Open|August 9, 2023
Invasive fungal diseases in patients with autoimmune diseases: a case series from the French RESSIF networkSimon Galmiche, Benjamin Thoreau, Stéphane Bretagne, et al.
Pageof 18